Amy Whitehead

5.1k citations

22 papers · 2.8k indexed · 3 hit papers · h-index 11

Impact in

Applied Psychology top 5%
- Digital Mental Health Interventions
Rehabilitation top 2%
- Stroke Rehabilitation and Recovery

Papers in

Statistics, Probability and Uncertainty 9
- Meta-analysis and systematic reviews 9
Statistics and Probability 6
- Statistical Methods in Clinical Trials 6

Co-authors: Steven A. Julious Michael J. Campbell Cindy CooperSophie BillinghamStephen J. Walters Neil Shephard Munyaradzi Dimairo Richard Jacques
Journals: Trials (6 papers)Journal of Clinical Oncology (2 papers)BMC Medical Research Methodology (2 papers)Clinical Cancer Research (1 paper)BMJ Open (1 paper)
Partner nations: United Kingdom Malaysia Jordan

In The Last Decade

Amy Whitehead

22 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable 2015 · 1.1k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Statistical Methods in Medical Research
2014 Trials
2013 BMC Medical Research Methodology

Peers

Countries citing papers authored by Amy Whitehead

Since Specialization

Citations

This map shows the geographic impact of Amy Whitehead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Whitehead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Whitehead more than expected).

Fields of papers citing papers by Amy Whitehead

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Whitehead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Whitehead. The network helps show where Amy Whitehead may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy Whitehead, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy Whitehead Line = papers co-authored together Amy Whitehead links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial European Urology ·Simon J. Crabb, Gareth Griffiths, Denise Dunkley, Nichola Downs, Mary Ellis, Mike Radford, Michelle Light, Josh Northey, Amy Whitehead, Sam Wilding, Alison Birtle, Vincent Khoo, Robert J. Jones	2022	30
2	Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease Trials ·Hugh Gallagher, Jennifer Dumbleton, Tom Maishman, Amy Whitehead, Michael Moore, Ahmet Fuat, David Fitzmaurice, Robert Henderson, Joanne Lord, Kathryn E Griffith, Paul E. Stevens, Maarten W. Taal, Diane Stevenson, Simon Fraser, Mark Lown, Christopher J. Hawkey, Paul Roderick	2022	10
3	Updated overall survival (OS) analysis for ProCAID: A randomized, double-blind, placebo-controlled phase II trial of capivasertib with docetaxel versus docetaxel alone in metastatic castration-sensitive prostate cancer (mCRPC). Journal of Clinical Oncology ·Simon J. Crabb, Gareth Griffiths, Denise Dunkley, Nichola Downs, Mary Ellis, Mike Radford, Michelle Light, Josh Northey, Amy Whitehead, Sam Wilding, Claire Rooney, Carolina Salinas-Souza, Alison Birtle, Vincent Khoo, Robert J. Jones	2022	2
4	Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE) Clinical Cancer Research ·Simon J. Crabb, Sarah Danson, James W.F. Catto, Syed A. Hussain, Danna Chan, Denise Dunkley, Nichola Downs, Ellice Marwood, Laura Day, Geoff Saunders, Michelle Light, Amy Whitehead, Deborah Ellis, Naveed Sarwar, Deborah Enting, Alison Birtle, Bernadette Johnson, Robert Huddart, Gareth Griffiths	2021	17
5	The Optimising Cardiac Surgery ouTcOmes in People with diabeteS (OCTOPuS) randomised controlled trial to evaluate an outpatient pre-cardiac surgery diabetes management intervention: a study protocol BMJ Open ·Richard I. G. Holt, Giorgos Dritsakis, Katharine Barnard‐Kelly, Kerensa Thorne, Amy Whitehead, Lauren Cohen, Elizabeth Dixon, Mayank Patel, Philip Newland‐Jones, Mark Green, Helen Partridge, Suvitesh Luthra, Sunil K. Ohri, Kareem Salhiyyah, Joanne Lord, John Niven, Andrew Cook	2021	4
6	Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial BMC Complementary Medicine and Therapies ·Merlin Willcox, Catherine Simpson, Sam Wilding, Beth Stuart, Dia Soilemezi, Amy Whitehead, Alannah Morgan, Emma Wrixon, Shihua Zhu, Guiqing Yao, Fran Webley, Ruiyang Yan, Jennifer Bostock, Margaret Bell, Gareth Griffiths, Geraldine Leydon, Paul Little, Christopher Butler, Alastair D Hay, Michael Moore	2021	8
7	ProCAID: A randomized double-blind phase II clinical trial of capivasertib (C) in combination with docetaxel and prednisolone chemotherapy (DP) in metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology ·Simon J. Crabb, Gareth Griffiths, Ellice Marwood, Denise Dunkley, Nichola Downs, Karen Martin, Michelle Light, Josh Northey, Amy Whitehead, Emily Shaw, Alison Birtle, Amit Bahl, Tony Elliott, Charlotte Westbury, Santhanam Sundar, Angus Robinson, Satinder Jagdev, Satish Kumar, Vincent Khoo, Robert J. Jones	2020	2
8	HATRIC: a study of Pelargonium sidoides root extract EPs®7630 (Kaloba®) for the treatment of acute cough due to lower respiratory tract infection in adults—study protocol for a double blind, placebo-controlled randomised feasibility trial Pilot and Feasibility Studies ·Amy Whitehead, Catherine Simpson, Merlin Willcox, Frances Webley, Alastair D Hay, Christopher Butler, Lily Yao, Emma Wrixon, Margaret Bell, Jennifer Bostock, Paul Little, Gareth Griffiths, Michael Moore	2019	7
9	Guidance for using pilot studies to inform the design of intervention trials with continuous outcomes Clinical Epidemiology ·Melanie L. Bell, Amy Whitehead, Steven A. Julious	2018	151
10	SPIRE – combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial Trials ·Simon J. Crabb, Sarah Danson, James W.F. Catto, Cathy McDowell, James N. Lowder, Joshua Caddy, Denise Dunkley, Jessica Rajaram, Deborah A. Ellis, Stephanie Hill, David Hathorn, Amy Whitehead, M. Kalevras, Robert Huddart, Gareth Griffiths	2018	9
11	Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): Mature analysis of overall survival (OS) in the New EPOC randomised controlled trial Annals of Oncology ·John Bridgewater, S. Pugh, Amy Whitehead, Louise Stanton, Zina Eminton, J. M. MELLOR, Amanda Allen, Meg Finch-Jones, S. Falk, Timothy Iveson, M. Rees, Juan W. Valle, Joanne Hornbuckle, Tamas Hickish, David Cunningham, Tim Maughan, James Garden, Gareth Griffiths, John Primrose	2017	3
12	Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable Statistical Methods in Medical Research ·Amy Whitehead, Steven A. Julious, Cindy Cooper, Michael J. Campbell Hit paper breakdown →	2015	1083
13	Do pilot trials reliably predict recruitment and retention rates for full trial? A review of HTA funded trials Trials ·Amy Whitehead, Cindy Cooper, Steven A. Julious, Edward Pottrill	2015	2
14	Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study Trials ·M. Dawn Teare, Munyaradzi Dimairo, Neil Shephard, Alex Hayman, Amy Whitehead, Stephen J. Walters Hit paper breakdown →	2014	424
15	Pilot and feasibility studies: Is there a difference from each other and from a randomised controlled trial? Contemporary Clinical Trials ·Amy Whitehead, Benjamin Sully, Michael J. Campbell	2014	133
16	The statistical interpretation of pilot trials: should significance thresholds be reconsidered? BMC Medical Research Methodology ·Ellen Lee, Amy Whitehead, Richard Jacques, Steven A. Julious	2014	286
17	An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database BMC Medical Research Methodology ·Sophie Billingham, Amy Whitehead, Steven A. Julious Hit paper breakdown →	2013	558
18	Mometasone Furoate Significantly Reduces Radiation Dermatitis in Patients Undergoing Breast Radiation Therapy: A Double-Blind Randomized Control Trial in 120 Patients International Journal of Radiation OncologyBiologyPhysics ·Kelly E. Dunn, Andrew Hindley, Lisa J. Wood, A. Sanneh, David Barber, Amy Whitehead, Zahrah Zakiyah	2013	3
19	Sample size requirements for pilot randomised controlled trials with continuous outcomes: a simulation study Trials ·M. Dawn Teare, Alexandra Hayman, Munyaradzi Dimairo, Neil Shephard, Amy Whitehead, Stephen J. Walters	2013	2
20	51. Efficacy and safety of once daily tobramycin in treating acute respiratory exacerbations in adult patients The Netherlands Journal of Medicine ·Amy Whitehead	1999	13

About Amy Whitehead

Amy Whitehead is a scholar working on Statistics, Probability and Uncertainty, Statistics and Probability, Economics and Econometrics, Emergency Medical Services and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 2.8k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Meta-analysis and systematic reviews (9 papers), Statistical Methods in Clinical Trials (6 papers), Prostate Cancer Treatment and Research (3 papers), Health and Medical Research Impacts (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Epigenetics and DNA Methylation (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Applied Psychology (180 citations), Rehabilitation (170 citations), Psychiatry and Mental health (366 citations), Clinical Psychology (479 citations) and Geriatrics and Gerontology (74 citations). Amy Whitehead has collaborated with scholars based in United Kingdom, Malaysia and Jordan. Frequent co-authors include Steven A. Julious, Michael J. Campbell, Cindy Cooper, Sophie Billingham, Stephen J. Walters, Neil Shephard, Munyaradzi Dimairo, Richard Jacques, Ellen Lee and M. Dawn Teare. Their work appears in journals such as Trials, Journal of Clinical Oncology, BMC Medical Research Methodology, Clinical Cancer Research and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact